Dec 17, 2025
202:201
For every 201 shares held, investors received 202. The price per share adjusted from $27.75 to $27.61.
The split itself did not change the total investment value.
Taiwan Bio Therapeutics Co., Ltd. (TPEX:6892) operates in the Biotechnology industry.
Taiwan Bio Therapeutics Co., Ltd. company overviewTaiwan Bio Therapeutics Co., Ltd.'s most recent stock split was on December 17, 2025. It was a 202-for-201 forward split, so shareholders received 202 shares for every 201 they held.
Taiwan Bio Therapeutics Co., Ltd. (TPEX:6892) has split its stock 2 times: a 635-for-613 split on April 27, 2023 and a 202-for-201 split on December 17, 2025.
Taiwan Bio Therapeutics Co., Ltd. has split its stock 2 times. This history records 2 forward splits between April 27, 2023 and December 17, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Taiwan Bio Therapeutics Co., Ltd.'s 202-for-201 split on December 17, 2025, every 201 shares became 202 shares.
Taiwan Bio Therapeutics Co., Ltd. has not announced a new split in our records. Its most recent split was on December 17, 2025, less than a year ago. Companies announce splits in advance, and any new TPEX:6892 split will appear on this page.
Already premium?